National multicenter study of eligibility for interferon and ribavirin therapy in patients coinfected with HIV and hepatitis C

被引：0
|
作者：
Bini, EJ
Currie, S
Shen, H
Brau, N
Schmidt, W
Wright, TL
机构：
来源：
GASTROENTEROLOGY | 2004年 / 126卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A695 / A695
页数：1
相关论文
共 50 条
  • [21] Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis c virus during interferon-ribavirin combination treatment
    Bani- Sadr, F
    Carrat, F
    Rosenthal, E
    Piroth, L
    Morand, P
    Lunel-Fabiani, F
    Bonarek, M
    de Verdiere, NC
    Pialoux, G
    Cacoub, P
    Pol, S
    Perronne, C
    CLINICAL INFECTIOUS DISEASES, 2005, 41 (12) : 1806 - 1809
  • [22] Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin
    Bani-Sadr, Firouze
    Goderel, Isabelle
    Lapidus, Nathanael
    Driss, Henda
    Simon, Anne
    Rosenthal, Eric
    Morand, Patrice
    Lunel-Fabiani, Francoise
    Pol, Stanislas
    Cacoub, Patrice
    Perronne, Christian
    Carrat, Fabrice
    AIDS, 2008, 22 (11) : 1385 - 1387
  • [23] Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus-Coinfected Patients with Advanced Immunosuppression
    Mira, Jose A.
    Gutierrez-Valencia, Alicia
    Gil, Ignacio De los Santos
    Merino, Dolores
    Rivero, Antonio
    Rios-Villegas, Maria J.
    Delgado, Marcial
    Gonzalez-Serrano, Mercedes
    Collado, Antonio
    Torres-Tortosa, Manuel
    Omar, Mohamed
    Angel Lopez-Ruz, Miguel
    Macias, Juan
    Arponen, Sari
    Pineda, Juan A.
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (08) : E84 - E91
  • [24] Therapy Insight: management of hepatitis C in patients coinfected with HIV
    Mark S Sulkowski
    Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 : 223 - 231
  • [25] Interferon and ribavirin therapy in dialysis patients with chronic hepatitis C
    Bruchfeld, A
    Ståhle, L
    Andersson, J
    Schvarcz, R
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (08) : 1729 - 1729
  • [26] Therapy Insight: management of hepatitis C in patients coinfected with HIV
    Sulkowski, MS
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (05): : 223 - 231
  • [27] Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: Analysis of risk factors
    Bani-Sadr, Firouze
    Lapidus, Nathanael
    Bedossa, Pierre
    De Boever, Corinne Merle
    Perronne, Christian
    Halfon, Philippe
    Pol, Stanislas
    Carrat, Fabrice
    Cacoub, Patrice
    CLINICAL INFECTIOUS DISEASES, 2008, 46 (05) : 768 - 774
  • [28] Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin
    Rodriguez-Novoa, Sonia
    Morello, Judit
    Gonzalez, Mar
    Vispo, Eugenia
    Barreiro, Pablo
    Gonzalez-Pardo, Gema
    Jimenez-Nacher, Inmaculada
    Gonzalez-Lahoz, Juan
    Soriano, Vincent
    AIDS, 2008, 22 (18) : 2535 - 2537
  • [29] Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy
    Bani-Sadr, F
    Carrat, F
    Pol, S
    Hor, R
    Rosenthal, E
    Goujard, C
    Morand, P
    Lunel-Fabiani, F
    Salmon-Ceron, D
    Piroth, L
    Pialoux, G
    Bentata, M
    Cacoub, P
    Perronne, C
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (01) : 47 - 52
  • [30] Long-term efficacy of dose intensified interferon-α 2b and ribavirin therapy for hepatitis C in HIV-coinfected patients
    Mannah, M
    Rockstroh, JK
    Gölz, J
    Klausen, G
    Dupke, S
    Stein, L
    Notheis, G
    Stoehr, A
    Mauss, S
    GASTROENTEROLOGY, 2002, 122 (04) : A528 - A528
12345